Pephexia Therapeutics ApS — Credit Rating and Financial Key Figures

Pephexia Therapeutics ApS (CVR number: 41319208) is a company from FREDERIKSBERG. The company recorded a gross profit of -2085.4 kDKK in 2024. The operating profit was -5800.9 kDKK, while net earnings were -5320.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -29.7 %, which can be considered poor and Return on Equity (ROE) was -95.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -72.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Pephexia Therapeutics ApS's liquidity measured by quick ratio was 5.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.